🇺🇸 FDA
Pipeline program

UBT251

TUL-UBT251(II-4)202503

Phase 2 small_molecule active

Quick answer

UBT251 for Obesity &Amp; Overweight is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Obesity &Amp; Overweight
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials